Theravance Biopharma
TBPH
TBPH
112 hedge funds and large institutions have $567M invested in Theravance Biopharma in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 45 reducing their positions, and 15 closing their positions.
Holders
112
Holders Change
-8
Holders Change %
-6.67%
% of All Funds
1.89%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
9
Increased
35
Reduced
45
Closed
15
Calls
$1.28M
Puts
$1.24M
Net Calls
+$44K
Net Calls Change
+$4.27M
Top Buyers
Top Sellers
1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$959K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$59.3M |
3 |
3
Goldman Sachs
New York
|
$5.28M |
4 |
4
Morgan Stanley
New York
|
$3.57M |
5 |
BG
5
Baupost Group
Boston,
Massachusetts
|
$122M |